SVRA Savara, Inc. - Common Stock
$5,40
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 11, 2026
Zakres 52 tyg.
$3–$7
61% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$11
+103% upside
P/E (TTM)
-10.2
ROE
-73.4%
Marża Zysku Netto
—
SVRA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$5.40
Kapitalizacja Rynkowa
$1.11B
P/E (TTM)
-10.2
EPS (TTM)
$-0.53
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-73.4%
D/E Dług/Kapitał
0.1
Zakres 52 tyg.
$3 – $7
SVRA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
2016-12-31
→
2020-12-31
EPS
$-0.53
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-101M
2016-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
SVRA
Mediana porównawcza
P/E (TTM)
-10.2
—
P/B
5.4
5.2
EV / EBITDA
-7.3
—
Price / FCF (Cena / FCF)
-10.9
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
SVRA
Mediana porównawcza
ROA
-51.0%
-44.7%
ROE
-73.4%
-51.5%
ROIC
-53.0%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
SVRA
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.1
0.0
Current Ratio (Wskaźnik bieżący)
11.8
9.5
Quick Ratio (Wskaźnik Szybkości)
11.6
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
SVRA
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
SVRA
Mediana porównawcza
SVRA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 5 35,7%
- Kup 8 57,1%
- Trzymaj 1 7,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
8 analityków · 2026-08-17
Mediana
$10.25
Średnia
$10.94
← Poniżej wszystkich celów
$5.40
Niski
$9.00
Wysoki
$16.00
Średni cel
$10.25
+89,8%
Średnia cel
$10.94
+102,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.15 | $-0.14 | -0.01% |
| 31 grudnia 2025 | $-0.13 | $-0.12 | -0.01% |
| 30 września 2025 | $-0.14 | $-0.14 | -0.00% |
| 30 czerwca 2025 | $-0.14 | $-0.12 | -0.02% |
| 31 marca 2025 | $-0.12 | $-0.13 | 0.01% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| ODTX | — | — | — | — | — | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $257.0K | $0 | · | $0 | $400.0K | $54.0K | $0 | |
| SG&A Expense | $42M | $25M | $16M | $11M | $12M | $14M | $13M | $11M | $11M | $3M | $2M | $9M | |
| Operating Expenses | $124M | $103M | $60M | $39M | $41M | $50M | $79M | $70M | $30M | $11M | $6M | $29M | |
| Operating Income | $-124M | $-103M | $-60M | $-39M | $-41M | $-49M | $-79M | $-70M | $-30M | $-11M | $-6M | $-29M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1M | $452.0K | $3M | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $122.0K | $130.0K | $69.0K | |
| Other Non-op | $5M | $7M | $5M | $689.0K | $-2M | $-315.0K | $852.0K | $1M | $-3M | $-332.0K | $-3M | $508.0K | |
| Pretax Income | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-69M | $-33M | $-11M | $-9M | $-29M | |
| Income Tax | $0 | $9.0K | · | · | · | · | · | $-7M | $-4M | $-357.0K | $0 | $0 | |
| Net Income | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-62M | $-30M | $-11M | $-9M | $-29M | |
| EPS (Basic) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 | · | · | · | · | · | · | · | |
| Shares (Basic) | 222,387,531 | 198,191,936 | 165,204,652 | 152,771,817 | 133,919,145 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 222,387,531 | 198,191,936 | 165,204,652 | 152,771,817 | 133,919,145 | · | · | · | · | · | · | · | |
| EBITDA | $-124M | · | $-60M | $-39M | $-41M | $-49M | $-78M | $-70M | $-30M | $-36M | $-39M | $-29M |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $33M | $15M | $27M | $52M | $34M | $23M | $50M | $24M | $22M | $13M | $17M | $13M | |
| Short-term Investments | $203M | $181M | $136M | $74M | $127M | $59M | $72M | $87M | $72M | $0 | · | · | |
| Prepaid Expense | $6M | $6M | $4M | $3M | $4M | $3M | $2M | $3M | $4M | $840.0K | $1M | $1M | |
| Current Assets | $242M | $202M | $166M | $129M | $165M | $85M | $124M | $113M | $98M | $15M | $42M | $58M | |
| PP&E (Net) | $100.0K | $165.0K | $270.0K | $51.0K | $73.0K | $156.0K | $352.0K | $522.0K | $925.0K | $793.0K | $226.0K | $188.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $565.0K | $532.0K | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $851.0K | $504.0K | $339.0K | $344.0K | |
| Goodwill | · | · | · | · | · | $0 | · | $27M | $27M | $3M | $3M | $3M | |
| Other Non-current Assets | $84.0K | $242.0K | $387.0K | $116.0K | $251.0K | $250.0K | $673.0K | $131.0K | $131.0K | $131.0K | $183.0K | $353.0K | |
| Total Assets | $253M | $213M | $178M | $140M | $177M | $98M | $136M | $152M | $160M | $29M | $54M | $70M | |
| Accounts Payable | $6M | $5M | $4M | $1M | $1M | $3M | $3M | $4M | $3M | $536.0K | $3M | $1M | |
| Accrued Liabilities | $15M | $10M | $7M | $5M | $5M | $6M | $5M | $3M | $3M | $2M | $8M | $6M | |
| Current Liabilities | $20M | $15M | $11M | $6M | $15M | $8M | $11M | $7M | $6M | $3M | $23M | $8M | |
| Capital Leases | · | $100.0K | $200.0K | $50.0K | $100.0K | $100.0K | $300.0K | · | $297.0K | $579.0K | $25.0K | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $7M | $2M | $3M | $3M | |
| Other Non-current Liabilities | $0 | $87.0K | $247.0K | $54.0K | $117.0K | $84.0K | $513.0K | $70.0K | · | · | · | · | |
| Total Liabilities | $50M | $41M | $37M | $32M | $32M | $33M | $35M | $44M | $40M | $21M | $30M | $12M | |
| Long-term Debt | $30M | $27M | $26M | $26M | $26M | $25M | · | · | · | · | · | · | |
| Total Debt | $30M | · | $26M | $26M | $26M | · | · | · | · | · | · | · | |
| Common Stock | $204.0K | $173.0K | $140.0K | $116.0K | $116.0K | $55.0K | $52.0K | $36.0K | $32.0K | $5.0K | $164.0K | $159.0K | |
| Retained Earnings | $-608M | $-489M | $-393M | $-339M | $-301M | $-258M | $-208M | $-130M | $-68M | $-38M | $-275M | $-235M | |
| AOCI | $-87.0K | $-750.0K | $-271.0K | $-605.0K | $5.0K | $942.0K | $-17.0K | $200.0K | $958.0K | $-591.0K | $-17.0K | $-25.0K | |
| Stockholders' Equity | $203M | $171M | $140M | $108M | $144M | $64M | $102M | $108M | $119M | $-36M | $-27M | $-18M | |
| Liabilities + Equity | $253M | $213M | $178M | $140M | $177M | $98M | $136M | $152M | $160M | $29M | $54M | $70M | |
| Shares Outstanding | 204,567,283 | 172,423,223 | 138,143,545 | 114,046,345 | 114,036,892 | 54,152,955 | 50,790,441 | 35,146,096 | 30,509,522 | 3,162,573 | 163,614,297 | 159,458,376 |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $130.0K | $77.0K | $31.0K | $136.0K | $255.0K | $1M | $526.0K | · | $99.0K | $146.0K | $85.0K | |
| Stock-based Comp | $14M | $10M | $4M | $2M | $3M | $5M | $4M | $4M | $552.0K | $209.0K | $153.0K | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | $-7M | $-3M | $-2M | · | · | |
| Other Non-cash | · | · | · | · | · | · | $28M | · | · | · | · | · | |
| Operating Cash Flow | $-101M | $-89M | $-51M | $-35M | $-40M | $-40M | $-45M | $-39M | $-28M | $-8M | $-5M | $-25M | |
| CapEx | $22.0K | $25.0K | $296.0K | $9.0K | $57.0K | $47.0K | $148.0K | $141.0K | $495.0K | $8.0K | $165.0K | $147.0K | |
| Investing Cash Flow | $-18M | $-40M | $-57M | $53M | $-69M | $9M | $16M | $-14M | $-69M | · | · | · | |
| Debt Issued | $30M | · | · | $26M | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $2M | · | · | $88.0K | · | · | · | · | $-4M | · | · | · | |
| Stock Issued | · | · | · | · | · | $2M | $30M | $505.0K | $2M | $20M | $2M | $30M | |
| Net Stock Activity | · | · | · | · | · | $2M | $30M | $505.0K | $2M | $20M | $2M | $30M | |
| Financing Cash Flow | $138M | $118M | $83M | $87.0K | $121M | $4M | $55M | $55M | $106M | · | · | · | |
| Net Change in Cash | $18M | $-11M | $-26M | $18M | $11M | $-27M | $26M | $2M | $9M | $-3M | $4M | $10M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-101M | · | $-51M | $-35M | $-40M | $-40M | $-45M | $-39M | $-29M | $-37M | $-33M | $-25M | |
| Levered FCF | · | · | · | · | · | · | · | · | $-30M | $-39M | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -19182.9% | · | · | · | -28481.2% | · | · | |
| Net Margin | · | · | · | · | · | -19305.5% | · | · | · | -28203.1% | · | · | |
| Pretax Margin | · | · | · | · | · | -19305.5% | · | · | · | -30085.2% | · | · | |
| EBITDA Margin | · | · | · | · | · | -19182.9% | · | · | · | -28481.2% | · | · | |
| ROA | -51.0% | · | -34.5% | -24.1% | -31.4% | -42.4% | -54.2% | -39.4% | -31.6% | -100.1% | -63.9% | -45.6% | |
| ROE | -73.4% | · | -38.1% | -34.0% | -28.7% | -70.4% | -75.0% | -54.4% | -71.4% | 410.9% | -1425.5% | -53.9% | |
| ROIC | -53.0% | · | · | · | · | · | · | -56.9% | -22.4% | -350.2% | · | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | · | 15.7 | 22.0 | 11.3 | 10.4 | 11.4 | 15.6 | 16.3 | 2.5 | 1.8 | 6.9 | |
| Quick Ratio | 11.6 | · | 15.3 | 21.5 | 11.0 | 10.1 | 11.2 | 15.3 | 15.7 | 1.8 | 1.0 | 4.2 | |
| Debt / Equity | 0.1 | · | 0.2 | 0.2 | 0.2 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | · | 0.2 | 0.2 | 0.1 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -25.8 | -17.1 | -65.3 | · |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $257.0K | $0 | · | $0 | $400.0K | $54.0K | $0 | |
| Net Income TTM | $-119M | $-96M | $-55M | $-38M | $-43M | $-50M | $-78M | $-62M | $-30M | $-11M | $-9M | $-29M | |
| Market Cap | $1.23B | · | $649M | $177M | $141M | $62M | $228M | $266M | $453M | · | · | · | |
| Enterprise Value | $1.03B | · | $513M | $77M | $6M | · | · | · | · | · | · | · | |
| P/E | -11.4 | -6.4 | -14.2 | -6.2 | -3.9 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | 242.3 | · | · | · | · | · | · | |
| P/B | 6.1 | · | 4.6 | 1.6 | 1.0 | 1.0 | 2.2 | 2.5 | 3.8 | · | · | · | |
| P / Tangible Book | 6.1 | 3.1 | 4.6 | 1.6 | 1.0 | 1.0 | · | · | · | · | · | · | |
| P / Cash Flow | -12.2 | · | -12.7 | -5.1 | -3.5 | -1.6 | -5.0 | -6.8 | -16.0 | · | · | · | |
| P / FCF | -12.2 | · | -12.6 | -5.1 | -3.5 | -1.6 | -5.0 | -6.7 | -15.8 | · | · | · | |
| EV / EBITDA | -8.3 | · | -8.6 | -2.0 | -0.1 | · | · | · | · | · | · | · | |
| EV / FCF | -10.2 | · | -10.0 | -2.2 | -0.1 | · | · | · | · | · | · | · | |
| Earnings Yield | -8.8% | -15.6% | -7.0% | -16.1% | -25.8% | · | · | · | · | · | · | · |
Rachunek zysków i strat 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $19M | $16M | $13M | $10M | $11M | $9M | $8M | $6M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $2M | |
| Operating Expenses | $41M | $39M | $33M | $30M | $31M | $28M | $31M | $26M | $23M | $22M | $18M | $18M | $12M | $12M | $11M | $11M | |
| Operating Income | $-41M | $-39M | $-33M | $-30M | $-31M | $-28M | $-31M | $-26M | $-23M | $-22M | $-18M | $-18M | $-12M | $-12M | $-11M | $-11M | |
| Other Non-op | $737.0K | $2M | $1M | $694.0K | $1M | $2M | $2M | $2M | $947.0K | $2M | $2M | $1M | $778.0K | $2M | $575.0K | $149.0K | |
| Pretax Income | · | · | · | · | · | $-27M | · | · | · | $-20M | · | · | · | · | · | · | |
| Net Income | $-40M | $-37M | $-32M | $-30M | $-30M | $-27M | $-29M | $-24M | $-22M | $-20M | $-16M | $-17M | $-11M | $-11M | $-10M | $-10M | |
| EPS (Basic) | $-0.16 | $-0.15 | $-0.13 | $-0.14 | $-0.14 | $-0.12 | $-0.14 | $-0.11 | $-0.12 | $-0.11 | $-0.09 | $-0.10 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | |
| EPS (Diluted) | $-0.16 | $-0.15 | $-0.13 | $-0.14 | $-0.14 | $-0.12 | $-0.14 | $-0.11 | $-0.12 | $-0.11 | $-0.09 | $-0.10 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | |
| Shares (Basic) | 253,569,891 | 253,280,551 | -426,652,912 | 216,462,161 | 216,431,348 | 216,146,934 | -378,789,902 | 211,847,651 | 182,584,078 | 182,550,109 | -315,069,736 | 174,696,191 | 152,796,617 | 152,781,580 | -305,541,525 | 152,773,015 | |
| Shares (Diluted) | 253,569,891 | 253,280,551 | -426,652,912 | 216,462,161 | 216,431,348 | 216,146,934 | -378,789,902 | 211,847,651 | 182,584,078 | 182,550,109 | -315,069,736 | 174,696,191 | 152,796,617 | 152,781,580 | -305,541,525 | 152,773,015 | |
| EBITDA | $-41M | $-39M | · | $-30M | $-31M | $-28M | · | $-26M | $-23M | $-22M | · | $-18M | $-12M | $-12M | · | $-11M |
Bilans 23
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $42M | $39M | $33M | $16M | $17M | $20M | $15M | $21M | $24M | $17M | $27M | $28M | $23M | $34M | $52M | $120M | |
| Short-term Investments | $131M | $164M | $203M | $108M | $129M | $153M | $181M | $198M | $98M | $126M | $136M | $141M | $82M | $81M | $74M | $14M | |
| Prepaid Expense | $5M | $6M | $6M | $4M | $5M | $5M | $6M | $7M | $6M | $3M | $4M | $2M | $3M | $3M | $3M | $3M | |
| Current Assets | $178M | $209M | $242M | $128M | $151M | $177M | $202M | $226M | $128M | $146M | $166M | $170M | $108M | $118M | $129M | $137M | |
| PP&E (Net) | $641.0K | $130.0K | $100.0K | $85.0K | $119.0K | $138.0K | $165.0K | $206.0K | $236.0K | $248.0K | $270.0K | $277.0K | $264.0K | $47.0K | $51.0K | $59.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Other Non-current Assets | $2M | $886.0K | $84.0K | $990.0K | $1M | $1M | $242.0K | $1M | $1M | $1M | $387.0K | $1M | $888.0K | $868.0K | $116.0K | $876.0K | |
| Total Assets | $192M | $222M | $253M | $141M | $164M | $189M | $213M | $239M | $140M | $158M | $178M | $182M | $120M | $129M | $140M | $148M | |
| Accounts Payable | $7M | $4M | $6M | $4M | $5M | $6M | $5M | $5M | $3M | $3M | $4M | $3M | $3M | $2M | $1M | $893.0K | |
| Accrued Liabilities | $11M | $11M | $15M | $13M | $9M | $6M | $10M | $8M | $8M | $7M | $7M | $6M | $3M | $3M | $5M | $4M | |
| Current Liabilities | $18M | $16M | $20M | $17M | $14M | $12M | $15M | $13M | $11M | $10M | $11M | $9M | $6M | $5M | $6M | $5M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | $300.0K | · | · | · | · | |
| Other Non-current Liabilities | $770.0K | · | $0 | $0 | $0 | $44.0K | $87.0K | $128.0K | $169.0K | $208.0K | $247.0K | $284.0K | $20.0K | $37.0K | $54.0K | $71.0K | |
| Total Liabilities | $48M | $46M | $50M | $47M | $43M | $41M | $41M | $39M | $38M | $36M | $37M | $36M | $32M | $31M | $32M | $31M | |
| Long-term Debt | $30M | $30M | $30M | $30M | $30M | $30M | · | $27M | $26M | $26M | · | $26M | $26M | $26M | · | $26M | |
| Total Debt | $30M | $30M | · | $30M | $30M | $30M | · | $27M | $26M | $26M | · | $26M | $26M | $26M | · | $26M | |
| Common Stock | $204.0K | $204.0K | $204.0K | $173.0K | $173.0K | $173.0K | $173.0K | $172.0K | $140.0K | $140.0K | $140.0K | $137.0K | $116.0K | $116.0K | $116.0K | $116.0K | |
| Retained Earnings | $-686M | $-645M | $-608M | $-576M | $-546M | $-516M | $-489M | $-460M | $-436M | $-414M | $-393M | $-377M | $-361M | $-349M | $-339M | $-328M | |
| AOCI | $-534.0K | $-429.0K | $-87.0K | $-155.0K | $-216.0K | $-632.0K | $-750.0K | $299.0K | $-880.0K | $-742.0K | $-271.0K | $-942.0K | $-619.0K | $-461.0K | $-605.0K | $-2M | |
| Stockholders' Equity | $144M | $176M | $203M | $94M | $120M | $148M | $171M | $199M | $102M | $122M | $140M | $147M | $88M | $98M | $108M | $117M | |
| Liabilities + Equity | $192M | $222M | $253M | $141M | $164M | $189M | $213M | $239M | $140M | $158M | $178M | $182M | $120M | $129M | $140M | $148M | |
| Shares Outstanding | 205,399,365 | 204,922,140 | 204,567,283 | 172,850,443 | 172,836,922 | 172,703,390 | 172,423,223 | 170,842,763 | 138,199,047 | 138,176,641 | 138,143,545 | 135,339,836 | 114,150,455 | 114,064,736 | 114,046,345 | 114,042,642 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $28.0K | $24.0K | $-13.0K | $35.0K | $34.0K | $30.0K | $32.0K | $33.0K | $33.0K | $32.0K | $31.0K | $30.0K | $8.0K | $8.0K | $7.0K | $8.0K | |
| Stock-based Comp | $8M | $11M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $995.0K | $958.0K | $864.0K | $561.0K | $450.0K | |
| Operating Cash Flow | $-30M | $-33M | $-25M | $-23M | $-26M | $-27M | $-23M | $-23M | $-22M | $-21M | $-16M | $-13M | $-10M | $-12M | $-9M | $-8M | |
| CapEx | $222.0K | $54.0K | $2.0K | $2.0K | $15.0K | $3.0K | $-9.0K | $3.0K | $21.0K | $10.0K | $24.0K | $43.0K | $225.0K | $4.0K | $0 | $4.0K | |
| Investing Cash Flow | $33M | $39M | $-94M | $21M | $24M | $29M | $18M | $-98M | $30M | $11M | $7M | $-57M | $-1M | $-6M | $-59M | $33M | |
| Debt Issued | · | · | $0 | $0 | $0 | $30M | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $189.0K | $-195.0K | $136M | $-23.0K | $-49.0K | $2M | $-843.0K | $118M | $55.0K | $49.0K | $8M | $75M | $104.0K | $26.0K | $1.0K | $-1.0K | |
| Net Change in Cash | $3M | $6M | $17M | $-1M | $-2M | $4M | $-6M | $-2M | $7M | $-10M | $-1M | $5M | $-11M | $-18M | $-68M | $25M | |
| Free Cash Flow | · | $-33M | · | · | · | $-27M | · | · | · | $-21M | · | · | · | $-12M | · | · |
Rentowność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -22.6% | -18.1% | · | -15.6% | -20.0% | -15.3% | · | -11.5% | -17.1% | -14.1% | · | -10.1% | -8.3% | -7.1% | · | -6.2% | |
| ROE | -30.5% | -23.0% | · | -20.1% | -27.4% | -19.8% | · | -14.0% | -23.5% | -18.5% | · | -12.6% | -10.7% | -9.0% | · | -7.6% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.1 | 13.5 | · | 7.7 | 11.1 | 14.9 | · | 17.7 | 11.3 | 14.9 | · | 19.0 | 18.3 | 23.9 | · | 26.5 | |
| Quick Ratio | 9.8 | 13.0 | · | 7.4 | 10.7 | 14.5 | · | 17.2 | 10.8 | 14.6 | · | 18.8 | 17.9 | 23.3 | · | 26.0 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.3 | · | 0.2 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.3 | · | 0.2 |
Wycena (TTM) 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-137M | $-124M | · | $-111M | $-104M | $-93M | · | $-83M | $-71M | $-59M | · | $-49M | $-42M | $-38M | · | $-38M | |
| Market Cap | $1.27B | $1.12B | · | $617M | $394M | $478M | · | $724M | $557M | $688M | · | $512M | $365M | $222M | · | $177M | |
| Enterprise Value | $1.12B | $946M | · | $522M | $277M | $335M | · | $531M | $462M | $571M | · | $370M | $286M | $134M | · | $69M | |
| P/E | -10.4 | -9.9 | · | -7.0 | -4.7 | -6.0 | · | -9.6 | -10.1 | -14.2 | · | -12.2 | -11.8 | -7.8 | · | -6.2 | |
| P/B | 8.8 | 6.4 | · | 6.5 | 3.3 | 3.2 | · | 3.6 | 5.5 | 5.6 | · | 3.5 | 4.2 | 2.3 | · | 1.5 | |
| P / Tangible Book | 8.8 | 6.4 | · | 6.5 | 3.3 | 3.2 | · | 3.6 | 5.5 | 5.6 | · | 3.5 | 4.2 | 2.3 | · | 1.5 | |
| P / Cash Flow | · | -33.9 | · | · | · | -17.6 | · | · | · | -33.3 | · | · | · | -18.5 | · | · | |
| P / FCF | · | -33.8 | · | · | · | -17.6 | · | · | · | -33.3 | · | · | · | -18.5 | · | · | |
| EV / EBITDA | -27.4 | -24.3 | · | -17.3 | -8.8 | -11.8 | · | -20.2 | -19.9 | -25.4 | · | -20.5 | -23.4 | -11.0 | · | -6.5 | |
| EV / FCF | · | -28.6 | · | · | · | -12.3 | · | · | · | -27.7 | · | · | · | -11.1 | · | · | |
| Earnings Yield | -9.6% | -10.1% | · | -14.3% | -21.5% | -16.6% | · | -10.4% | -9.9% | -7.0% | · | -8.2% | -8.5% | -12.8% | · | -16.1% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-119M | $-96M | $-55M | $-38M | $-43M |
| Rozwodniony EPS | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.1 | — | 0.2 | 0.2 | 0.2 |
| Wskaźnik bieżący | 11.8 | — | 15.7 | 22.0 | 11.3 |
| Wskaźnik Szybkości | 11.6 | — | 15.3 | 21.5 | 11.0 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-101M | — | $-51M | $-35M | $-40M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 197 emitentów · $1.2B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 32 (-23 vs poprzedni kw.) | 25 (+6 vs poprzedni kw.) | 69 (+7 vs poprzedni kw.) | 54 (+13 vs poprzedni kw.) | +12.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| NEA Management Company, LLC | $150 742 986 | 24 471 264 | 12,35% | Akcje |
| Bain Capital Life Sciences Investors, LLC | $108 419 826 | 17 600 621 | 8,88% | Akcje |
| Venrock Adviser, LLC | $90 835 009 | 14 745 943 | 7,44% | Akcje |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $83 585 040 | 13 569 000 | 6,85% | Akcje |
| TCG Crossover Management, LLC | $76 151 183 | 12 362 205 | 6,24% | Akcje |
| Frazier Life Sciences Management, L.P. | $59 880 448 | 9 720 852 | 4,90% | Akcje |
| Polar Capital Holdings Plc | $58 777 402 | 9 541 786 | 4,81% | Akcje |
| VANGUARD GROUP INC | $54 222 146 | 8 992 064 | 4,44% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $48 864 477 | 7 932 545 | 4,00% | Akcje |
| Nantahala Capital Management, LLC | $42 977 150 | 6 976 810 | 3,52% | Akcje |
| STATE STREET CORP | $40 368 624 | 6 553 348 | 3,31% | Akcje |
| RTW INVESTMENTS, LP | $36 666 661 | 5 952 380 | 3,00% | Akcje |
| Woodline Partners LP | $26 149 933 | 4 245 119 | 2,14% | Akcje |
| ORBIMED ADVISORS LLC | $24 392 984 | 3 959 900 | 2,00% | Akcje |
| Spruce Street Capital LP | $21 267 868 | 3 452 576 | 1,74% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $20 600 575 | 3 343 378 | 1,69% | Akcje |
| Rosalind Advisors, Inc. | $19 577 225 | 3 178 121 | 1,60% | Akcje |
| EMERALD ADVISERS, LLC | $19 394 384 | 3 148 439 | 1,59% | Akcje |
| Pictet Asset Management Holding SA | $17 020 419 | 2 763 055 | 1,39% | Akcje |
| Vestal Point Capital, LP | $16 755 200 | 2 720 000 | 1,37% | Akcje |
| Affinity Asset Advisors, LLC | $15 474 862 | 2 512 153 | 1,27% | Akcje |
| EMERALD MUTUAL FUND ADVISERS TRUST | $14 636 154 | 2 375 999 | 1,20% | Akcje |
| NAN FUNG TRINITY (HK) LTD | $11 348 876 | 1 842 350 | 0,93% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10 076 762 | 1 635 838 | 0,83% | Akcje |
| ADAR1 Capital Management, LLC | $8 644 999 | 1 403 409 | 0,71% | Akcje |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8 349 627 | 1 355 459 | 0,68% | Akcje |
| ALGERT GLOBAL LLC | $8 188 235 | 1 329 259 | 0,67% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $7 417 447 | 1 204 131 | 0,61% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7 211 802 | 1 170 747 | 0,59% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $6 412 597 | 1 041 006 | 0,53% | Akcje |
| Longaeva Partners L.P. | $6 257 864 | 1 015 887 | 0,51% | Akcje |
| SUPERSTRING CAPITAL MANAGEMENT LP | $6 021 154 | 977 460 | 0,49% | Akcje |
| MARSHALL WACE, LLP | $5 458 967 | 886 196 | 0,45% | Akcje |
| SPHERA FUNDS MANAGEMENT LTD. | $4 657 970 | 756 164 | 0,38% | Akcje |
| Swedbank AB | $4 409 944 | 715 900 | 0,36% | Akcje |
| F/m Investments LLC | $4 055 461 | 658 354 | 0,33% | Akcje |
| GOLDMAN SACHS GROUP INC | $3 891 144 | 631 679 | 0,32% | Akcje |
| Sio Capital Management, LLC | $3 804 878 | 617 675 | 0,31% | Akcje |
| AXA Investment Managers S.A. | $3 760 142 | 1 053 261 | 0,31% | Akcje |
| KVP Capital Advisors, LP | $3 728 525 | 605 280 | 0,31% | Akcje |
| Integral Health Asset Management, LLC | $3 696 000 | 600 000 | 0,30% | Akcje |
| D. E. Shaw & Co., Inc. | $3 120 890 | 506 638 | 0,26% | Akcje |
| Moody Aldrich Partners LLC | $2 974 005 | 482 793 | 0,24% | Akcje |
| BANK OF AMERICA CORP /DE/ | $2 811 837 | 456 467 | 0,23% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $2 529 351 | 410 609 | 0,21% | Akcje |
| Sofinnova Investments, Inc. | $2 246 940 | 364 763 | 0,18% | Akcje |
| Seven Fleet Capital Management LP | $1 904 074 | 309 103 | 0,16% | Akcje |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1 681 669 | 307 998 | 0,14% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $1 533 156 | 248 889 | 0,13% | Akcje |
| Walleye Capital LLC | $1 532 115 | 248 720 | 0,13% | Akcje |
| HighVista Strategies LLC | $1 493 054 | 242 379 | 0,12% | Akcje |
| Eversept Partners, LP | $1 259 276 | 204 428 | 0,10% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1 236 693 | 205 090 | 0,10% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $1 205 851 | 195 755 | 0,10% | Akcje |
| RHUMBLINE ADVISERS | $1 146 187 | 186 071 | 0,09% | Akcje |
| Swiss National Bank | $1 139 600 | 185 000 | 0,09% | Akcje |
| FMR LLC | $1 064 676 | 172 837 | 0,09% | Akcje |
| CITADEL ADVISORS LLC | $1 053 797 | 171 071 | 0,09% | Akcje |
| CITIGROUP INC | $923 335 | 149 892 | 0,08% | Akcje |
| Jain Global LLC | $879 605 | 142 793 | 0,07% | Akcje |
| WELLS FARGO & COMPANY/MN | $859 708 | 139 563 | 0,07% | Akcje |
| XTX Topco Ltd | $754 662 | 122 510 | 0,06% | Akcje |
| GLENMEDE TRUST CO NA | $707 432 | 114 843 | 0,06% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $693 638 | 127 040 | 0,06% | Akcje |
| BlackRock, Inc. | $646 196 | 104 902 | 0,05% | Akcje |
| DCF Advisers, LLC | $616 000 | 100 000 | 0,05% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $585 921 | 95 117 | 0,05% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $574 728 | 93 300 | 0,05% | Opcja kupna |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $554 400 | 90 000 | 0,05% | Akcje |
| MetLife Investment Management, LLC | $549 817 | 89 256 | 0,05% | Akcje |
| Bank of New York Mellon Corp | $549 330 | 89 177 | 0,04% | Akcje |
| Rafferty Asset Management, LLC | $547 279 | 88 844 | 0,04% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $531 534 | 86 288 | 0,04% | Akcje |
| Cresset Asset Management, LLC | $513 337 | 83 334 | 0,04% | Akcje |
| MORGAN STANLEY | $496 096 | 80 535 | 0,04% | Akcje |
| Birchview Capital, LP | $492 800 | 80 000 | 0,04% | Akcje |
| Vanguard Global Advisers, LLC | $473 291 | 76 833 | 0,04% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $461 236 | 74 876 | 0,04% | Akcje |
| Optimize Financial Inc | $459 202 | 84 103 | 0,04% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $432 130 | 70 151 | 0,04% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $430 492 | 69 885 | 0,04% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $405 427 | 65 816 | 0,03% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $388 560 | 63 078 | 0,03% | Akcje |
| Virtus Investment Advisers, LLC | $383 183 | 62 205 | 0,03% | Akcje |
| JPMORGAN CHASE & CO | $382 459 | 63 426 | 0,03% | Akcje |
| Verdad Advisers, LP | $380 435 | 61 759 | 0,03% | Akcje |
| Invesco Ltd. | $375 526 | 60 962 | 0,03% | Akcje |
| FIFTH THIRD BANCORP | $333 595 | 54 155 | 0,03% | Akcje |
| Avidity Partners Management LP | $308 000 | 50 000 | 0,03% | Akcje |
| Sivia Capital Partners, LLC | $298 760 | 48 500 | 0,02% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $293 450 | 47 638 | 0,02% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $285 824 | 46 400 | 0,02% | Opcja sprzedaży |
| PROFUND ADVISORS LLC | $285 645 | 46 371 | 0,02% | Akcje |
| DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. | $283 360 | 46 000 | 0,02% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $280 003 | 45 455 | 0,02% | Akcje |
| Jump Financial, LLC | $273 504 | 44 400 | 0,02% | Akcje |
| SEI INVESTMENTS CO | $267 523 | 43 429 | 0,02% | Akcje |
| CITADEL ADVISORS LLC | $256 872 | 41 700 | 0,02% | Opcja sprzedaży |
| Police & Firemen's Retirement System of New Jersey | $250 324 | 40 637 | 0,02% | Akcje |
| JANUS HENDERSON GROUP PLC | $247 018 | 45 200 | 0,02% | Akcje |
Insiderzy spółki 59 insiderów · 30 dyrektorzy generalni · 25 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Matthew Pauls | CHIEF EXECUTIVE OFFICER | 16 grudnia 2025 G | 1 188 050 | 0 | 0 | $0 |
| Robert N Neville | Chief Executive Officer | 20 grudnia 2019 A | 498 028 | 0 | 0 | $0 |
| Brian M Culley | CEO and Director | 20 stycznia 2017 A | 34 500 | 0 | 0 | $0 |
| Evan Levine | CEO & President | 8 lutego 2008 P | 4 395 000 | 0 | 0 | $0 |
| Nicholas J Virca | CEO and President | 15 grudnia 2003 X | 347 956 | 0 | 0 | $0 |
| David L Lowrance | Chief Financial Officer | 22 czerwca 2026 M | 536 032 | 0 | 1 | $-2 240 919 |
| Brandi Roberts | Chief Financial Officer & SVP | 20 stycznia 2017 A | 38 000 | 0 | 0 | $0 |
| Gregory P Hanson | Senior VP, CFO & Treasurer | 20 grudnia 2006 A | — | 0 | 0 | $0 |
| Carrie Carlander | CFO, Treas, Secy, VP Finance | 31 stycznia 2006 A | 25 000 | 0 | 0 | $0 |
| Jaakko Taneli Jouhikainen | President and Chief Operating Officer | 20 grudnia 2019 A | 167 569 | 0 | 0 | $0 |
| Patrick L Keran | President & COO | 2 stycznia 2015 A | — | 0 | 0 | $0 |
| James A Merritt | President & Chf Med Officer | 12 stycznia 2007 A | — | 0 | 0 | $0 |
| Robert Matthew Lutz | Chief Fin. & Operating Officer | 15 lipca 2026 A | 328 977 | 0 | 0 | $0 |
| Kathleen R. Mccabe | Chief Legal Officer | 14 grudnia 2025 F | 519 232 | 0 | 0 | $0 |
| Anne Erickson | Chief Business Officer | 14 grudnia 2025 F | 371 712 | 0 | 0 | $0 |
| Yasmine Wasfi | Chief Medical Officer | 4 grudnia 2025 F | 168 008 | 0 | 0 | $0 |
| Braden C. Parker | Chief Commercial Officer | 12 grudnia 2024 A | 105 000 | 0 | 0 | $0 |
| Raymond Dennis Pratt | Chief Medical Officer | 12 grudnia 2024 A | 340 050 | 0 | 0 | $0 |
| Badrul A. Chowdhury | CHIEF MEDICAL OFFICER | 14 grudnia 2021 A | 300 000 | 0 | 0 | $0 |
| Shana Hood | General Counsel & VP | 20 stycznia 2017 A | — | 0 | 0 | $0 |
| Edwin L. Parsley | Chief Medical Officer & SVP | 20 stycznia 2017 A | — | 0 | 0 | $0 |
| Gregory D. Gorgas | Senior VP, Commercial | 4 stycznia 2016 A | — | 0 | 0 | $0 |
| Robert Martin Emanuele | Senior VP, Development | 4 stycznia 2016 A | 294 598 | 0 | 0 | $0 |
| Santosh Vetticaden | Chief Medical Officer & SVP | 19 czerwca 2014 A | — | 0 | 0 | $0 |
| Mark E. Erwin | SVP, Operations | 30 stycznia 2009 A | — | 0 | 0 | $0 |
| Michele Yelmene | VP, Regulatory & QA | 30 stycznia 2009 A | — | 0 | 0 | $0 |
| Joachim Ph Schupp | VP, Medical Affairs | 31 marca 2008 A | — | 0 | 0 | $0 |
| Joan M Robbins | SVP & Chief Science Officer | 31 marca 2008 A | 146 500 | 0 | 0 | $0 |
| Mark Joseph Cantwell | VP, Research & Development | 12 stycznia 2007 A | — | 0 | 0 | $0 |
| Cellia Habita | Senior VP, Clinical & Medical | 7 października 2004 P | 5 000 | 0 | 0 | $0 |
| Joseph S Mccracken | Dyrektor | 16 lutego 2026 M | 302 644 | 0 | 0 | $0 |
| David A Ramsay | Dyrektor | 19 grudnia 2025 S | 2 533 642 | 0 | 1 | $-121 200 |
| An Van Es-Johansson | Dyrektor | 9 grudnia 2025 A | 102 500 | 0 | 0 | $0 |
| Nevan C Elam | Dyrektor | 9 grudnia 2025 A | 106 887 | 0 | 0 | $0 |
| Richard J Hawkins | Dyrektor | 9 grudnia 2025 A | 161 326 | 0 | 0 | $0 |
| Ricky Sun | Dyrektor | 14 grudnia 2023 A | 22 500 | 0 | 0 | $0 |
| Yuri Pikover | Dyrektor | 13 grudnia 2018 A | 153 734 | 0 | 0 | $0 |
| Peter Greenleaf | Dyrektor | 20 stycznia 2017 A | — | 0 | 0 | $0 |
| DITTRICH HOWARD | Dyrektor | 20 stycznia 2017 A | — | 0 | 0 | $0 |
| Lewis Shuster | Dyrektor | 11 czerwca 2015 A | — | 0 | 0 | $0 |
| Jack Lief | Dyrektor | 11 czerwca 2015 A | — | 0 | 0 | $0 |
| Ted W Love | Dyrektor | 19 czerwca 2013 A | — | 0 | 0 | $0 |
| Odysseas D Kostas | Dyrektor | 30 czerwca 2010 A | — | 0 | 0 | $0 |
| Eric K Rowinsky | Dyrektor | 30 czerwca 2010 A | — | 0 | 0 | $0 |
| Mark Jerome Pykett | Dyrektor | 30 czerwca 2010 A | 8 000 | 0 | 0 | $0 |
| Michael M Goldberg | Dyrektor | 30 czerwca 2010 A | 26 000 | 0 | 0 | $0 |
| DENNER ALEXANDER J | Dyrektor | 30 czerwca 2008 A | — | 0 | 0 | $0 |
| Mark Bagnall | Dyrektor | 23 maja 2007 A | — | 0 | 0 | $0 |
| Ross M Johnson | Dyrektor | 21 grudnia 2006 X | 1 621 779 | 0 | 0 | $0 |
| Meister, Keith A. | Dyrektor | 2 czerwca 2006 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 7 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Growth Equity Opportunities 17, LLC, New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×4 zgłoszenia | 14 listopada 2025 | 12,00% | Aneks | Inwestycja pasywna | SEC |
| Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP ×5 zgłoszenia | 27 marca 2025 | 9,99% | Aneks | — | SEC |
| High River Limited Partnership, Hopper Investments LLC, Barberry Corp., Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn | 30 grudnia 2015 | — | Pierwotne zgłoszenie | — | SEC |
| Evan M. Levine, Mark Capital, LLC | 6 lutego 2009 | — | Pierwotne zgłoszenie | — | SEC |
| Evan Levine, Mark Capital, LLC ×2 zgłoszenia | 19 grudnia 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Matthew Balk ×2 zgłoszenia | 1 czerwca 2006 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| High River Limited Partnership S.S. OR, Hopper Investments LLC S.S. OR, Barberry Corp. S.S. OR, Icahn Partners Master Fund LP S.S. OR, Icahn Offshore LP S.S. OR, CCI Offshore Corp. S.S. OR, Icahn Partners LP S.S. OR, Icahn Onshore LP S.S. OR, CCI Onshore Corp. S.S. OR, Carl C. Icahn S.S. OR | 5 sierpnia 2005 | — | Pierwotne zgłoszenie | Kampania zarządu | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 38 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3,22% | 651 024 NS | 31 maja 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,56% | 39 885 NS | 30 kwietnia 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,21% | 203 377 NS | 30 kwietnia 2026 | N-PORT |
| IWC · iShares Trust | 0,20% | 519 481 SH | 8 sierpnia 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,09% | 301 950 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 11 152 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 163 980 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,06% | 1 401 936 SH | 8 sierpnia 2026 | Dziennie |
| BIB · ProShares Trust | 0,05% | 7 524 NS | 31 maja 2026 | N-PORT |
| IBB · iShares Trust | 0,05% | 777 564 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 880 662 SH | 8 sierpnia 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,03% | 70 061 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 3 921 924 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,02% | 62 952 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 105 661 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,02% | 6 895 NS | 31 maja 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 33 621 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 646 784 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 5 393 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1 567 813 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 277 850 SH | 8 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,01% | 11 041 SH | 8 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | 0,01% | 4 332 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,01% | 5 454 NS | 31 maja 2026 | N-PORT |
| ISCG · iShares Trust | 0,01% | 12 910 SH | 8 sierpnia 2026 | Dziennie |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 9 739 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 31 710 NS | 30 kwietnia 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 5 605 SH | 8 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,00% | 18 178 NS | 30 kwietnia 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 80 699 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 137 NS | 31 maja 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 42 652 SH | 8 sierpnia 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 170 824 SH | 8 sierpnia 2026 | Dziennie |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 80 211 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 23 796 NS | 30 kwietnia 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1 747 NS | 31 maja 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 6 164 961 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11 396 SH | 8 sierpnia 2026 | Dziennie |